166 related articles for article (PubMed ID: 36476110)
1. Combined Radiomics-Clinical Model to Predict Radiotherapy Response in Inoperable Stage III and IV Non-Small-Cell Lung Cancer.
Chen W; Wang L; Hou Y; Li L; Chang L; Li Y; Xie K; Qiu L; Mao D; Li W; Xia Y
Technol Cancer Res Treat; 2022; 21():15330338221142400. PubMed ID: 36476110
[No Abstract] [Full Text] [Related]
2. Dosiomics and radiomics improve the prediction of post-radiotherapy neutrophil-lymphocyte ratio in locally advanced non-small cell lung cancer.
Hou R; Xia W; Zhang C; Shao Y; Zhu X; Feng W; Zhang Q; Yu W; Fu X; Zhao J
Med Phys; 2024 Jan; 51(1):650-661. PubMed ID: 37963229
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment
Dissaux G; Visvikis D; Da-Ano R; Pradier O; Chajon E; Barillot I; Duvergé L; Masson I; Abgral R; Santiago Ribeiro MJ; Devillers A; Pallardy A; Fleury V; Mahé MA; De Crevoisier R; Hatt M; Schick U
J Nucl Med; 2020 Jun; 61(6):814-820. PubMed ID: 31732678
[TBL] [Abstract][Full Text] [Related]
4. A Radiomics Signature in Preoperative Predicting Degree of Tumor Differentiation in Patients with Non-small Cell Lung Cancer.
Chen X; Fang M; Dong D; Wei X; Liu L; Xu X; Jiang X; Tian J; Liu Z
Acad Radiol; 2018 Dec; 25(12):1548-1555. PubMed ID: 29572049
[TBL] [Abstract][Full Text] [Related]
5. Application of radiomics signature captured from pretreatment thoracic CT to predict brain metastases in stage III/IV ALK-positive non-small cell lung cancer patients.
Xu X; Huang L; Chen J; Wen J; Liu D; Cao J; Wang J; Fan M
J Thorac Dis; 2019 Nov; 11(11):4516-4528. PubMed ID: 31903240
[TBL] [Abstract][Full Text] [Related]
6. Impact of feature selection methods and subgroup factors on prognostic analysis with CT-based radiomics in non-small cell lung cancer patients.
Sugai Y; Kadoya N; Tanaka S; Tanabe S; Umeda M; Yamamoto T; Takeda K; Dobashi S; Ohashi H; Takeda K; Jingu K
Radiat Oncol; 2021 Apr; 16(1):80. PubMed ID: 33931085
[TBL] [Abstract][Full Text] [Related]
7. Radiomics study for predicting the expression of PD-L1 in non-small cell lung cancer based on CT images and clinicopathologic features.
Sun Z; Hu S; Ge Y; Wang J; Duan S; Song J; Hu C; Li Y
J Xray Sci Technol; 2020; 28(3):449-459. PubMed ID: 32176676
[TBL] [Abstract][Full Text] [Related]
8. A radiomics model of predicting tumor volume change of patients with stage III non-small cell lung cancer after radiotherapy.
Yan M; Wang W
Sci Prog; 2021; 104(1):36850421997295. PubMed ID: 33687294
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal radiomics of cone-beam CT images from non-small cell lung cancer patients: Evaluation of the added prognostic value for overall survival and locoregional recurrence.
van Timmeren JE; van Elmpt W; Leijenaar RTH; Reymen B; Monshouwer R; Bussink J; Paelinck L; Bogaert E; De Wagter C; Elhaseen E; Lievens Y; Hansen O; Brink C; Lambin P
Radiother Oncol; 2019 Jul; 136():78-85. PubMed ID: 31015133
[TBL] [Abstract][Full Text] [Related]
10. Application and limitation of radiomics approach to prognostic prediction for lung stereotactic body radiotherapy using breath-hold CT images with random survival forest: A multi-institutional study.
Kakino R; Nakamura M; Mitsuyoshi T; Shintani T; Kokubo M; Negoro Y; Fushiki M; Ogura M; Itasaka S; Yamauchi C; Otsu S; Sakamoto T; Sakamoto M; Araki N; Hirashima H; Adachi T; Matsuo Y; Mizowaki T
Med Phys; 2020 Sep; 47(9):4634-4643. PubMed ID: 32645224
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive radiomic biomarkers for predicting pseudoprogression and hyperprogression in patients with non-small cell lung cancer treated with immune checkpoint inhibition.
Li Y; Wang P; Xu J; Shi X; Yin T; Teng F
Oncoimmunology; 2024; 13(1):2312628. PubMed ID: 38343749
[TBL] [Abstract][Full Text] [Related]
12. Value of pre-therapy
Zhang J; Zhao X; Zhao Y; Zhang J; Zhang Z; Wang J; Wang Y; Dai M; Han J
Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1137-1146. PubMed ID: 31728587
[TBL] [Abstract][Full Text] [Related]
13. CT-derived radiomic analysis for predicting the survival rate of patients with non-small cell lung cancer receiving radiotherapy.
Zhang N; Zhang X; Li J; Ren J; Li L; Dong W; Liu Y
Phys Med; 2023 Mar; 107():102546. PubMed ID: 36796178
[TBL] [Abstract][Full Text] [Related]
14. CT-based radiomics nomogram may predict who can benefit from adaptive radiotherapy in patients with local advanced-NSCLC patients.
Zhou C; Hou L; Tang X; Liu C; Meng Y; Jia H; Yang H; Zhou S
Radiother Oncol; 2023 Jun; 183():109637. PubMed ID: 36963440
[TBL] [Abstract][Full Text] [Related]
15. Computed Tomography-Based Radiomics Model to Predict Central Cervical Lymph Node Metastases in Papillary Thyroid Carcinoma: A Multicenter Study.
Li J; Wu X; Mao N; Zheng G; Zhang H; Mou Y; Jia C; Mi J; Song X
Front Endocrinol (Lausanne); 2021; 12():741698. PubMed ID: 34745008
[TBL] [Abstract][Full Text] [Related]
16. Cone-beam CT radiomics features might improve the prediction of lung toxicity after SBRT in stage I NSCLC patients.
Qin Q; Shi A; Zhang R; Wen Q; Niu T; Chen J; Qiu Q; Wan Y; Sun X; Xing L
Thorac Cancer; 2020 Apr; 11(4):964-972. PubMed ID: 32061061
[TBL] [Abstract][Full Text] [Related]
17. Radiomics for prediction of radiation-induced lung injury and oncologic outcome after robotic stereotactic body radiotherapy of lung cancer: results from two independent institutions.
Bousabarah K; Blanck O; Temming S; Wilhelm ML; Hoevels M; Baus WW; Ruess D; Visser-Vandewalle V; Ruge MI; Treuer H; Kocher M
Radiat Oncol; 2021 Apr; 16(1):74. PubMed ID: 33863358
[TBL] [Abstract][Full Text] [Related]
18. A short-term follow-up CT based radiomics approach to predict response to immunotherapy in advanced non-small-cell lung cancer.
Gong J; Bao X; Wang T; Liu J; Peng W; Shi J; Wu F; Gu Y
Oncoimmunology; 2022; 11(1):2028962. PubMed ID: 35096486
[TBL] [Abstract][Full Text] [Related]
19. A Comprehensive Nomogram Combining CT Imaging with Clinical Features for Prediction of Lymph Node Metastasis in Stage I-IIIB Non-small Cell Lung Cancer.
Zheng X; Shao J; Zhou L; Wang L; Ge Y; Wang G; Feng F
Ther Innov Regul Sci; 2022 Jan; 56(1):155-167. PubMed ID: 34699046
[TBL] [Abstract][Full Text] [Related]
20. Using contrast-enhanced CT and non-contrast-enhanced CT to predict EGFR mutation status in NSCLC patients-a radiomics nomogram analysis.
Yang X; Liu M; Ren Y; Chen H; Yu P; Wang S; Zhang R; Dai H; Wang C
Eur Radiol; 2022 Apr; 32(4):2693-2703. PubMed ID: 34807270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
